PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Robert F. Kennedy, Jr. Explains How Anthony Fauci Has Been Manipulating Science | Video: 14 Minutes 38 Seconds

Show Me

Twitter Censors a Content From a Respected Medical Conference That Americans Deserve to Know

Show Me

New Twitter CEO: ‘Why Should I Distinguish Between White People and Racists’

Show Me

“China is Laughing at Us:” Twitter Suspends Rep. Jim Banks and Censors Marjorie Taylor Greene for Pointing Out That “The First-Ever Female 4 Star Admiral,” Rachel Levine, is a MAN

Show Me

NICKI MINAJ: ‘Open Your F**king Eyes’ to COVID Censorship, Twitter Ban is ‘Making Me Think’ That ‘There’s Something Bigger’ Going On

Show Me

American Booksellers Association ‘Protects’ Twitter Account After Censorship Backlash

Show Me

(READ) Congressman demands Twitter release evidence of political collusion on tweet censorship

Show Me

Twitter, California Sued for Cooperating on Censorship

Show Me

LAWSUIT: Twitter Conspired With Democrats on ‘Orwellian’ Censorship of Election Concerns

Show Me

Democrats Push for More Censorship at Facebook, Google, Twitter Hearing

Show Me

Diversity Darling Finds Out Her Black Ancestor Owned Slaves | Paul Joseph Watson

Show Me

Fully ‘Vaccinated’ and Now He’s Dead | Colin Powell Dead At 84 | New York Post

Show Me

Colin Powell’s Facebook Page Announcement Sums Up Everything That’s Wrong with Political Ruling Class Today

Show Me

Never Forget | “How Silicon Valley, in a Show of Monopolistic Force, Destroyed Parler” | Glenn Greenwald

Show Me

Vaccine Adverse Story Of 12 Year Old Participant | Video: 6 Minutes

Show Me

So We’ve Known All Along That Coronavirus Vaccines Are Very Dangerous | “Immunization With SARS Coronavirus Vaccines Leads To Pulmonary Immunopathology On Challenge With The SARS Virus” | NIH

Show Me

The Covid-19 ‘Vaccine’ Is Ruining So Many Lives | “Jeremy Chardy: I Regret Getting Vaccinated, I Have Series Of Problems Now” | Tennis World

Show Me

During FDA Hearings On Covid-19 Booster Shots, Dr. Jessica Rose Demonstrates Israeli Data May Show Covid ‘Vaccinated’ Driving Variants

Show Me

The FDA Advisory Board Overwhelmingly Rejected Booster Vaccine Authorization For Those Under 65 | “CDC’s Walensky Defends Overruling Vaccine Advisory Panel on Boosters”

Show Me

FDA Hearings On mRNA ‘Vaccine’ | “Dr. Jessica Rose Discusses Adverse Effects And Death Due To Covid-19 ‘Vaccine'” l Video: 1 Minute 54 Seconds

Show Me

The Covid-19 ‘Vaccine’ Has Created A Silent & New Killing Field | Jodi O’Malley, R.N., U.S. Department Of Health Whistleblower | Video 7 Minutes 12 Seconds

Show Me

Role Of Ivermectin In The Prevention Of SARS-CoV-2 Infection Among Healthcare Workers In India: A Matched Case-Control Study | NIH

Show Me

The Whole World Has Known How To Treat And Conquer Covid-19 Since It’s Inception – Politics Has Kept Us In Chains | “Ivermectin prophylaxis leads to 73 per cent reduction in Covid infection: AIIMS-Bhubaneswar Study”

Show Me

FDA Panel Overwhelmingly Rejects Pfizer Booster for 16 and Older

Show Me

FDA says it does not buy fetal tissue — any more

Show Me

Dr. Malone Explains How The Covid-19 Treatment Protocol Is Making People Desperate | Video: 1 Minute 5 Seconds

Show Me

Dr. Malone, mRNA ‘Vaccine’ Inventor, Discusses Ivermectin Misinformation | Video: 2 Minute 59 Seconds

Show Me

Dr. Malone, mRNA ‘Vaccine’ Inventor, Speaks About The War Against Covid-19 Therapeutics | Video: 1 Minute 30 Seconds

Show Me

Ironic: Sweden Condemned By The Left For Not Locking Down, Yet Did Better Than Most Nations Combating Covid | “Sweden Bans Travelers From Israel, One of the Most Vaccinated Nations”

Show Me

Who’s Really Being Hospitalized? | “Breakthrough cases reach majority levels in some jurisdictions but numbers elude CDC.”

Show Me

We’ve Known For So Long | “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” | NIH

Show Me

Oh, What A Tangled Web We Weave, When First We Practise To Deceive! | “In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM)” | There Was A 74% Reduction In Covid-19 Deaths In 30 Days Using Ivermectin | NIH

Show Me

Dr. Malone Discusses How Long Covid Symptoms & mRNA Adverse Symptoms Match Up | Video: 3 Minutes 21 Seconds

Show Me

If You’ve Come To Think That You’re Being Lied To About Covid-19, You’re Not Alone | “Federal Judge Allows NIH Ivermectin Deception Case to Proceed” That The “NIH deceived the nation on a treatment for COVID-19.”

Show Me

You Didn’t Actually Believe The Talking Heads From The CDC & NIH, Like Fauci, Did You? | Now It’s Not Just Hydroxychloroquine & Zinc, Vitamin D3 & A Host Of AntiInflammatories In Our Arsenal, Invermectin Has Been Shown To Reduce Illness & Death As Published By The NIH

Show Me

The Saddest Covid-19 ‘Vaccine’ Deaths Are From Those Who Strongly Advocated Taking Them | “Lisa Shaw: Presenter’s death due to complications of Covid vaccine”

Show Me

Dr. Malone On Ivermectin and The Whole Plethora Of Therapeutics Available For Covid-19 | Video: 3 Minutes 44 Seconds

Show Me

When It Comes To Combating Covid-19 . . . First, Hydroxychloroquine & Zinc Was Demonized | Then, Vitamin D3 Was Trivialized | Now, The Smear Campaign Is Against Ivermectin, So Safe & Effective Researchers Call It The ‘Wonder Drug’ As Published By The National Institutes Of Health

Show Me

Mayo Clinic-Trained Pathologist Tells RFK, Jr.: Early Treatment Is Key to Fighting Delta Variant

Show Me

130+ UK Doctors: Failed COVID Policies Caused ‘Massive’ Harm, Especially to Children

Show Me